Toshihiko Inoue

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.

Kenji Sugio, Tatsuhiro Ishida, Hideki Yokoyama et al. · PubMed · 1992 · 167 citations

Ras Gene Mutations, Oncogenic Agent, Human Lung +15

Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: A comparative study with a low-dose rate system

Yasushi Shigematsu, Kinji Nishiyama, Norie Masaki et al. · International Journal of Radiation Oncology*Biology*Physics · 1983 · 167 citations

Adaptive Radiotherapy, High-dose Rate, Cervical Cancer +10

High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial

Yasuo Yoshioka, Takayuki Nose, Ken Yoshida et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 146 citations · Full text

Treatment Description, Urology, Surgical Oncology +7

Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region

Osamu Ishikawa, Hiroaki Ohhigashi, Teruki Teshima et al. · Journal of Surgical Oncology · 1989 · 96 citations

Surgical Oncology, Pathology, Surgery +17